LF
Longwood Fund
Venture CapitalActiveLongwood Fund finances science-based companies that develop novel solutions for medical problems.
28
Investments
10
Exits
$1.1B
AUM
35.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Longwood Fund.
Investment Thesis & Strategy
Longwood Fund invests in science-based companies across various stages, focusing on those developing novel solutions for medical problems.
Investment Activity
Deals per year over the last 7 years
1
20153
20161
20172
20183
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 28 companies
T
Tessera Therapeutics
Biotech · Series A, 2021
K
Kyverna Therapeutics
Biotech · Series A, 2021
X
Xilio Therapeutics
Biotech · Series A, 2019
V
Verve Therapeutics
Biotech · Series A, 2019
V
Vor Biopharma
Biotech · Series A, 2019
G
Gyroscope Therapeutics
Biotech · Series A, 2018
S
Sana Biotechnology
Biotech · Series A, 2018
O
Obsidian Therapeutics
Biotech · Series A, 2017
C
Cerevance
Biotech · Series A, 2016
S
Scholar Rock
Biotech · Series A, 2016
S
Surface Oncology
Biotech · Series A, 2016
R
Revolution Medicines
Biotech · Series A, 2015
Frequently Asked Questions
Longwood Fund focuses on Series A, Series B, Series C+ stage investments.